CNBC’s Annika Kim Constantino reports on the FDA's approval of the first GLP-1 pill for obesity from Wegovy maker Novo Nordisk. Got a confidential news tip? We want to hear from you. Sign up for free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results